Overview
1. Executive Summary (Confidence: High)
Luciole Medical has established a first-mover position in the brain monitoring market with a platform that measures critical brain function parameters across a broad range of hospital settings.[23] Headquartered in Zurich, the company is unique in having obtained market approval (CE-mark) for both its non-invasive adhesive patch and its intracranial probe.[23] In June 2023, Luciole significantly expanded its market presence and manufacturing capacity by acquiring Spiegelberg GmbH & Co. KG, a specialized German provider of neurosurgical equipment.[24] With a leadership team of seasoned MedTech executives, Luciole is transforming brain monitoring by establishing cerebral blood flow (CBF) and oxygenation as "vital signs" for better patient care.[23]
This is an extract of the full organization profile. To access the full company profile, .
